Multi-glycomic analysis of spheroid glycocalyx differentiates 2- and 3-dimensional cell models.


Journal

Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124

Informations de publication

Date de publication:
08 01 2023
Historique:
received: 04 08 2022
revised: 10 09 2022
accepted: 26 09 2022
pubmed: 9 11 2022
medline: 12 1 2023
entrez: 8 11 2022
Statut: ppublish

Résumé

A multi-glycomic method for characterizing the glycocalyx was employed to identify the difference between 2-dimensional (2D) and 3-dimensional (3D) culture models with two human colorectal cancer cell lines, HCT116 and HT29. 3D cell cultures are considered more representative of cancer due to their ability to mimic the microenvironment found in tumors. For this reason, they have become an important tool in cancer research. Cell-cell interactions increase in 3D models compared to 2D, indeed significant glycomic changes were observed for each cell line. Analyses included the N-glycome, O-glycome, glycolipidome, glycoproteome, and proteome providing the most extensive characterization of the glycocalyx between 3D and 2D thus far. The different glycoconjugates were affected in different ways. In the N-glycome, the 3D cells increased in high-mannose glycosylation and in core fucosylation. Glycolipids increased in sialylation. Specific glycoproteins were found to increase in the 3D cell, elucidating the pathways that are affected between the two models. The results show large structural and biological changes between the 2 models suggesting that the 2 are indeed very different potentially affecting individual outcomes in the study of diseases.

Identifiants

pubmed: 36345209
pii: 6809075
doi: 10.1093/glycob/cwac075
pmc: PMC9829041
doi:

Substances chimiques

Glycoproteins 0
Polysaccharides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2-16

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM049077
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Cells. 2021 Sep 04;10(9):
pubmed: 34571967
Metabolites. 2020 Dec 01;10(12):
pubmed: 33271860
Adv Drug Deliv Rev. 2014 Apr;69-70:42-51
pubmed: 24412474
Nat Protoc. 2020 Aug;15(8):2668-2704
pubmed: 32681150
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7633-7644
pubmed: 32213588
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
J Proteome Res. 2013 Mar 1;12(3):1090-100
pubmed: 23294139
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
Mol Cancer. 2018 Feb 19;17(1):35
pubmed: 29455645
Glycobiology. 2020 Oct 21;30(11):859-871
pubmed: 32337579
J Am Soc Mass Spectrom. 2015 Apr;26(4):577-86
pubmed: 25604392
Biotechnol J. 2008 Oct;3(9-10):1172-84
pubmed: 18566957
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Am J Transl Res. 2018 Jul 15;10(7):2055-2067
pubmed: 30093943
Chem Rev. 2018 Sep 12;118(17):7886-7930
pubmed: 29553244
EMBO Rep. 2006 Jun;7(6):599-604
pubmed: 16741504
Chem Sci. 2019 May 14;10(24):6199-6209
pubmed: 31360427
Cancers (Basel). 2019 Jan 04;11(1):
pubmed: 30621226
Mol Cell Proteomics. 2011 Jan;10(1):M110.002717
pubmed: 21097542
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
Int J Mol Sci. 2015 Dec 09;16(12):29278-304
pubmed: 26690136
Br J Cancer. 2005 Dec 12;93(12):1356-63
pubmed: 16333244
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396
pubmed: 34019663
J Surg Res. 2012 May 1;174(1):1-6
pubmed: 21816436
Chem Sci. 2018 Jun 27;9(29):6271-6285
pubmed: 30123482
Clin Proteomics. 2018 Mar 02;15:9
pubmed: 29507546
Glycobiology. 2019 Apr 1;29(4):320-331
pubmed: 30689864
Mol Cell Proteomics. 2016 Jan;15(1):124-40
pubmed: 26537799
Mol Ther. 2022 Apr 6;30(4):1523-1535
pubmed: 35077861
Nat Rev Nephrol. 2019 Jun;15(6):346-366
pubmed: 30858582
Sci Rep. 2020 Dec 1;10(1):21377
pubmed: 33262440
J Proteome Res. 2016 Dec 2;15(12):4265-4276
pubmed: 27696853
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Anal Chem. 2018 Jan 2;90(1):208-224
pubmed: 29049885
Methods Mol Biol. 2013;945:193-219
pubmed: 23097109
Front Oncol. 2013 Dec 19;3:306
pubmed: 24392350
Front Bioeng Biotechnol. 2016 Feb 12;4:12
pubmed: 26904541
PLoS One. 2016 Nov 30;11(11):e0165615
pubmed: 27902713
Glycobiology. 1994 Dec;4(6):873-84
pubmed: 7734850
Carbohydr Res. 2009 Aug 17;344(12):1387-90
pubmed: 19508951
J Biochem. 1988 Jun;103(6):998-1003
pubmed: 3170527

Auteurs

Qingwen Zhou (Q)

Department of Chemistry, University of California, Davis, CA, United States.

Michael Russelle S Alvarez (MRS)

Department of Chemistry, University of California, Davis, CA, United States.
Institute of Chemistry, University of the Philippines Los Banos, Los Banos, Laguna, Philippines.

Kemal Solakyildirim (K)

Department of Chemistry, University of California, Davis, CA, United States.
Department of Chemistry, Erzincan Binali Yildirim University, Erzincan, Turkey.

Jennyfer Tena (J)

Department of Chemistry, University of California, Davis, CA, United States.

Luster Mae N Serrano (LMN)

Institute of Chemistry, University of the Philippines Los Banos, Los Banos, Laguna, Philippines.

Matthew Lam (M)

Department of Chemistry, University of California, Davis, CA, United States.

Cynthia Nguyen (C)

Department of Chemistry, University of California, Davis, CA, United States.

Fernando Tobias (F)

Department of Chemistry and Biochemistry, The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.

Amanda B Hummon (AB)

Department of Chemistry and Biochemistry, The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.

Ruel C Nacario (RC)

Institute of Chemistry, University of the Philippines Los Banos, Los Banos, Laguna, Philippines.

Carlito B Lebrilla (CB)

Department of Chemistry, University of California, Davis, CA, United States.
Department of Chemistry, Biochemistry, Molecular, Cellular and Developmental Biology Graduate Group, University of California, Davis, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH